Last reviewed · How we verify

NCT02893852

Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder

Completed NA Last updated 15 February 2019
What this trial tests

NA trial testing standard CO-OP Approach in Motor Skills Disorders in 23 participants. Completed in 31 January 2019.

Timeline
12 May 2016
Primary endpoint
18 December 2017
31 January 2019

Quick facts

Lead sponsorFederal University of Minas Gerais
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment23
Start date12 May 2016
Primary completion18 December 2017
Estimated completion31 January 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Minas Gerais

Who can join

Adults 7 to 12, any sex, with Motor Skills Disorders or Attention Deficit and Disruptive Behavior Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effects of the Cognitive Orientation to daily daily Occupational Performance Approach (CO-OP Approach) on activity and participation in school-aged children with developmental coordination disorder (DCD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of CO-OP Approach With and Without Parental Coaching: RCT Study Protocol: Efficacité de l'approche CO-OP avec et sans coaching parental : protocole d'essai clinique randomisé.
    Araújo CRS, Cardoso AA, Magalhães LC. · · 2021 · cited 1× · PMID 33845626 · DOI 10.1177/00084174211005889

Verify or expand the search:

Other recruiting trials for Motor Skills Disorders

Currently open trials in the same condition.

Other Federal University of Minas Gerais trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02893852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing